SOLICITATION NOTICE
66 -- FDSS-uCell
- Notice Date
- 8/11/2010
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support/Simplified Acquisitions, 31 Center Drive, Room 1B59, Bethesda, Maryland, 20892
- ZIP Code
- 20892
- Solicitation Number
- RFQ1696541
- Archive Date
- 9/7/2010
- Point of Contact
- Korriise L. LaRoche, Phone: 301-435-8782
- E-Mail Address
-
larochek@mail.nih.gov
(larochek@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This is a not a total small business set-aside. This solicitation number is RFQ1696541 and the solicitation is issued as a Request for Quotation (RFQ) using FAR Part 13 - Simplified Acquisition Procedures and FAR Part 12 - Acquisition of Commercial Items. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-44. The National Institute on Drug Abuse (NIDA) on behalf of the National Institute of Neurological Disorders and Stroke (NINDS) has a requirement for a high-resolution kinetic plate reader used for high throughput drug screening. The instrument will be used to read and analyze experiments which include calcium accumulation assays with fluorescent readout, thallium flux assays with fluorescent readout, membrane potential assays with fluorescence readout, and beta arrestin translocation assays with luminescent readout. The instrument must be capable of reading both fluorescence and luminescence in order to run these assays. In addition, the instrument must be equipped with a camera that is capable of both readout modes in a single instrument. The instrument must be able to: (1) Accomplish image improvements during real time image processing, including background subtraction, shading correction recursive filter, frame averaging and spot noise reduction in order to optimize many different assays on a single instrument; (2) Have the Capability of both EM-CCD and Normal CCD readout to allow for the utmost versatility in assay development and also must include multiple readout speeds in each mode to match frame rates with the assay being developed; (3) Screen a relatively large (thousands) number of compounds on any given assay. The system must be able to read an entire well plate instantaneously, in real time; (4) Function in a kinetic (time dependent) manner as the assays are time sensitive and the signal must be read over varying time points. The instrument must be able to add multiple compounds to the plate wells and read the assay in real time as the compounds are being added. Offerors will be evaluated on their ability to meet technical specifications. Offers will also be evaluated on best value in relation to price. FOB Destination shall be Bethesda, MD 20892. Quotations are to be sent electronically to larochek@mail.nih.gov. Offerors must include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items, with its offer. Clause at 52.212-4, Contract Terms and Condition Commercial Items, applies to this acquisition. Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items, applies to this acquisition.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-2/RFQ1696541/listing.html)
- Record
- SN02237854-W 20100813/100812000609-4f5161757bd63d6ab9d3afd6114f92db (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |